Up a level |
Robinson, Ryan, Myerscough, Christopher A, He, Nengjie, Hill, Helen, Shepherd, Wendi, Gonzalez-Dias, Patricia, Liatsikos, Konstantinos, Latham, Samuel, Fyles, Fred, Doherty, Klara et al (show 15 more authors)
(2023)
Comprehensive review of safety in Experimental Human Pneumococcal Challenge.
PLOS ONE, 18 (5).
e0284399-.
Rylance, Jamie ORCID: 0000-0002-2323-3611, de Steenhuijsen Piters, Wouter ORCID: 0000-0002-1144-4067, Pojar, Sherin, Nikolaou, Elissavet, German, Esther, Mitsi, Elena, Jochems, Simon, Carniel, Beatriz, Solórzano, Carla, Reiné, Jesús et al (show 25 more authors)
(2018)
Effect of Live Attenuated Influenza Vaccine on Pneumococcal Carriage.
Robinson, Ryan E, Mitsi, Elena, Nikolaou, Elissavet, Pojar, Sherin, Chen, Tao ORCID: 0000-0002-5489-6450, Reine, Jesus, Nyazika, Tinashe K, Court, James, Davies, Kelly, Farrar, Madlen et al (show 24 more authors)
(2022)
Human Infection Challenge with Serotype 3 Pneumococcus.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 206 (11).
pp. 1379-1392.
Liatsikos, Konstantinos, Hyder-Wright, Angela, Pojar, Sherin, Chen, Tao ORCID: 0000-0002-5489-6450, Wang, Duolao, Davies, Kelly, Myerscough, Christopher, Reine, Jesus, Robinson, Ryan E, Urban, Britta et al (show 12 more authors)
(2022)
Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2).
BMJ Open, 12 (7).
e062109-e062109.
Hazenberg, Phoebe, Robinson, Ryan E, Farrar, Madlen, Solorzano, Carla, Hyder-Wright, Angela, Liatsikos, Konstantinos, Brunning, Jaye, Fleet, Hannah, Bettam, Amy, Howard, Ashleigh et al (show 9 more authors)
(2024)
Serotype 3 Experimental Human Pneumococcal Challenge (EHPC) study protocol: dose ranging and reproducibility in a healthy volunteer population (challenge 3).
BMJ open, 14 (1).
e075948-e075948.